Company intelligence / Profile preview

Batea Oncology

Santiago de Compostela, Galicia, Spainbateaoncology.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Batea Oncology has developed GlioHook, a Class III medical device designed to capture and concentrate residual glioblastoma cells after surgical resection. In animal models, GlioHook increased survival by 50% compared to radiotherapy alone. The company is currently completing regulatory preclinical studies and aims to begin a Phase I clinical trial in 2025 at three Spanish hospitals[1][2].

Therapeutic areas: Oncology
Modalities: Medical device (implantable biomaterial)Physical mechanism (not pharmacological)
Industry: Implantable Medical Devices

Drug pipeline

1 asset

GlioHook

Pre-clinical

Indications: Glioblastoma

Partnerships

Asociación Española Contra el Cáncer – AECC IMPACTO program funding/support[3]Clúster Tecnolóxico Empresarial das Ciencias da Vida – Bioga member/partner[2]Support from Xunta de Galicia/Xesgalicia for financing and business development[4]

Beyond the preview

Go deeper on Batea Oncology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Batea Oncology.

Explore the full profile